Questions
In what way does a mobile supermarket change the distribution channel?  Justify your answer. I WILL RATE!...

In what way does a mobile supermarket change the distribution channel?  Justify your answer. I WILL RATE! (marketing question but that is not a subject choice)

In: Economics

1. What is self-management? 2. What are some of the strategies to improve self-management?

1. What is self-management?

2. What are some of the strategies to improve self-management?

In: Economics

What Would You Do? Mylan Headquarters, Canonsburg, Pennsylvania It’s 2012 and Mylan, the company behind the...

What Would You Do?

Mylan Headquarters, Canonsburg, Pennsylvania

It’s 2012 and Mylan, the company behind the EpiPen Auto-Injector, is in the middle of a lawsuit. To settle, they agree to allow a generic competitor into the market in 2015, knowing this will cut into a big part of their business when the time comes. EpiPen is an epinephrine auto-injector used to treat emergency allergy reactions. EpiPen has been on the market since the 1980s but remains under patent because of the device, particularly the safety cap for the needle, not the active ingredient, epinephrine. Epinephrine is a hormone made by the body known as adrenaline and was first isolated more than 100 years ago. In the years leading up the 2012, Mylan had already been increasing the prices of EpiPen steadily. In 2007, the cost was around $100 for an EpiPen two pack; by 2011, $165. After the settlement, Mylan used a common practice in big pharmaceutical companies of sharply increasing the price of a medication in the years before a generic becomes available. It is a final attempt to make big profits off the brand-name drug before losing business to the generic. Drug manufacturers justify the high prices saying they cover the cost of years of research and development that went into creating the drug originally. Now it’s 2016, and Mylan is charging around $600 for an EpiPen two-pack. However, Teva, the expected generic, was rejected by the Food and Drug Administration, and Auvi-Q, EpiPen’s nongeneric competition, was pulled from the marked due to dosing problems. EpiPen now has a monopoly on the market for this lifesaving drug, and people are outraged by the price. With no alternatives available, customers and politicians alike are demanding answers and change. Senator Chuck Grassley (R-Iowa) wrote in a letter to Mylan CEO Heather Bresch, “I am concerned that the substantial price increase could limit access to a much needed medication.” Democratic presidential nominee, Hillary Clinton’s campaign spokesman Tyrone Gayle called for price cuts saying, “Since there is no apparent justification for the price increase, Mylan should immediately lower the overall price of EpiPens.” People suffering from life-threatening allergies won’t be the only ones affected by the price increase. Public schools and government institutions are among EpiPen customers because the medication is used for emergency treatment of allergic reactions. Bresch said she is as frustrated by the price increase as customers, saying “everyone should be frustrated.” She said the price reflects a system where intermediaries such as wholesalers, retailers, and pharmacies all add to the ultimate list price of the medication. The system also requires customers to pay insurance premiums and out-of-pocket costs for prescriptions medications. “The patient is paying twice,” Bresch said. “They’re paying full retail price at the counter, and they’re paying higher premiums on their insurance. It was never intended that a consumer, that the patients would be paying list price, never. The system wasn’t built for that.” In response to backlash from the high prices, Mylan announced plans to expand its co-pay assistance programs, double eligibility for its patient assistance program to 400% of the federal poverty level, continue to offer the EpiPen4Schools program, and open pathways so patients can order EpiPen directly from the company, thereby reducing the cost. EpiPen4Schools was launched in 2012 and has provided more than 700,000 free EpiPens to more than 65,000 schools nationwide. Representative Elijah Cummings (D-Maryland) was not impressed by Mylan’s announcement. “Offering a meager discount only after widespread bipartisan criticism is exactly the same tactic used by drug companies across the industry to distract from their exorbitant price increases,” Cummings said. “Nobody is buying this PR move anymore. Mylan should not offer after-the-fact discounts only for a select few — it should reverse its massive price increases across the board immediately.” After continued criticism, Bresch reiterated that price is only part of the problem. “All involved must also take steps to help meaningfully address the U.S. health care crisis,” she said, “and we are committed to do our part to drive change in collaboration with policymakers, payors, patients, and health care professionals.”

  1. As problems arise and solutions are pondered, who has the authority to make the ultimate decision? What is the best chain of command when big pronouncements have to be made? If you were CEO at Mylan, what would you do?
  2. The company will have to adapt to survive as more competitors enter the market. What benefits would there be to a change in organizational structure or process? Should departmentalization be considered for Mylan? If so, what type of departmentalization?

In: Economics

b) Describe one political effect of the Protestant Reformation in England in the period 1500–1600.

b) Describe one political effect of the Protestant Reformation in England in the period 1500–1600.

In: Economics

In your response, be sure to address all parts of the question. Use complete sentences; an...

In your response, be sure to address all parts of the question. Use complete sentences; an outline or bulleted list alone is not acceptable.

a) Describe one cause of the Protestant Reformation in England during the reign of Henry VIII (1509–1547).

In: Economics

c. Discuss a work situation in which you, a manager, or other employee had inadequate communications...

c. Discuss a work situation in which you, a manager, or other employee had inadequate communications skills (written or oral), which created a problem in the organization. Briefly summarize the situation and the problem(s) it created. Was action taken to remedy the problem or prevent it in the future? If action was taken, to what extent was it effective? If no action was taken, what if any action should have been taken? What did you learn from this experience, which will make you a more effective manager?

In: Economics

How Wall Street Works in NY?? & about the biggest day after NY bombed Iraq in...

How Wall Street Works in NY?? & about the biggest day after NY bombed Iraq in January 17th, 1991 leading the stock market to one of its biggest day. also, speak about the stocks & when to sell and about the bonds ? All based about how wall street works.

In: Economics

How well can we evaluate a regression equation “fits” the data by examining the R Square...

How well can we evaluate a regression equation “fits” the data by examining the R Square statistic, and test for statistical significance of each independent variable in the regression equation by using the t-test?

In: Economics

What are the primary opportunities and threats presented by the globalization of markets in business? Explain...

What are the primary opportunities and threats presented by the globalization of markets in business? Explain your answer.?

In: Economics

You have a process with the following parameters. What is the EUAW (EUAB-EUAC) for the process,...

You have a process with the following parameters. What is the EUAW (EUAB-EUAC) for the process, given a 15% interest rate?

First cost: $1.7M
O&M costs for Year 1: $29,000
Cost gradient: +$750/year (Year 2 is 29,750; year 3 is 30,500, and so forth)
Annual benefit: $303,000
Salvage value: $210,000
Useful life, in years: 20

In: Economics

Take any of the firms mentioned in the Modern Monopoly discussion thread and discuss the actual...

Take any of the firms mentioned in the Modern Monopoly discussion thread and discuss the actual competitive environment they compete in. The discussion can include information on market shares, but more importantly what are the true definitions of the markets and the list of competitors they face? How strong are these competitors? What creates advantages and disadvantages and how do these stack up? You should use the conditions necessary for Perfect Competition for a partial guide to this thread.

In: Economics

Using common layman terms how does the macroeconomy work?

Using common layman terms how does the macroeconomy work?

In: Economics

a phone manufacturer want to compete in the touch screen market. Management understands that the leading...

a phone manufacturer want to compete in the touch screen market. Management understands that the leading product has a less than desirable battery life. They aim to compete with a new touch screen phone that is guaranteed to have a battery more that two hours longer than the leading product. A recent sample of 109 units of the leading product provides a mean battery life of 5 hours and 51 minutes with a standard deviation of 42 minutes. A similar analysis of 90 units of the new product results in a mean battery life of 8 hours and 48 minutes and a standard deviation of 68 minutes. It is not reasonable to assume that the population variances of the two products are equal.

a. Set up the hypothesis to test if the new product has a battery life more than 2 hours longer than the leading product.

b-1 Calculate the value of the test statistic

In: Economics

How do household behavior and government policy influence the marketplace? Provide at least four examples with...

How do household behavior and government policy influence the marketplace? Provide at least four examples with well-written support. Please explain in brief.

In: Economics

How would inflation in a foreign country affect the value of foreign profits for a U.S...

How would inflation in a foreign country affect the value of foreign profits for a U.S investor?

In: Economics